YPEL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.604800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.520200E-01
Normal-vs-Stage2
2.589200E-01
Normal-vs-Stage3
2.191200E-01
Normal-vs-Stage4
2.880200E-01
Stage1-vs-Stage2
8.341000E-01
Stage1-vs-Stage3
1.819160E-01
Stage1-vs-Stage4
4.406600E-01
Stage2-vs-Stage3
1.098110E-02
Stage2-vs-Stage4
6.331200E-01
Stage3-vs-Stage4
1.365050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.589600E-01
Normal-vs-AfricanAmerican
2.240200E-01
Normal-vs-Asian
2.422200E-01
Caucasian-vs-AfricanAmerican
4.596400E-01
Caucasian-vs-Asian
4.637600E-01
AfricanAmerican-vs-Asian
3.714400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.460800E-01
Normal-vs-Female
2.800600E-01
Male-vs-Female
1.928480E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.701200E-01
Normal-vs-Age(41-60Yrs)
2.788600E-01
Normal-vs-Age(61-80Yrs)
2.552200E-01
Normal-vs-Age(81-100Yrs)
2.314600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.159000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.421200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.750200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.431990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.327900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.611000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.577400E-01
Normal-vs-Daily Drinker
2.863600E-01
Normal-vs-Weekly Drinker
2.670200E-01
Normal-vs-Occasional Drinker
2.572000E-01
Normal-vs-Social Drinker
2.660000E-01
Non Drinker-vs-Daily Drinker
4.823200E-01
Non Drinker-vs-Weekly Drinker
6.978600E-01
Non Drinker-vs-Occasional Drinker
9.744600E-01
Non Drinker-vs-Social Drinker
8.234000E-01
Daily Drinker-vs-Weekly Drinker
6.677200E-01
Daily Drinker-vs-Occasional Drinker
5.055200E-01
Daily Drinker-vs-Social Drinker
6.883000E-01
Weekly Drinker-vs-Occasional Drinker
7.111200E-01
Weekly Drinker-vs-Social Drinker
9.371400E-01
Occasional Drinker-vs-Social Drinker
8.068800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.164000E-01
Normal-vs-Grade 2
3.748600E-01
Normal-vs-Grade 3
4.738400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.525800E-01
Grade 1-vs-Grade 3
2.515800E-01
Grade 1-vs-Grade 4
4.164000E-01
Grade 2-vs-Grade 3
1.029380E-01
Grade 2-vs-Grade 4
3.748600E-01
Grade 3-vs-Grade 4
4.738400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.492200E-01
Normal-vs-NonDiabetic
2.684000E-01
Diabetic-vs-NonDiabetic
2.739600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.238300E-02
Normal-vs-NoPancreatitis
2.584600E-01
Pancreatitis-vs-NoPancreatitis
4.396600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.513000E-01
Normal-vs-N1
2.635200E-01
N0-vs-N1
4.182200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.322000E-01
Normal-vs-TP53-NonMutant
2.594200E-01
TP53-Mutant-vs-TP53-NonMutant
1.772160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
